Have a personal or library account? Click to login
Toxic and Adverse Effects of Chemotherapy with 5-Fluoropyrimidine Drugs. Could Dihydropyrimidine Dehydrogenase Enzyme Screening Serve as a Prerequisite to Successful Chemotherapy? Cover

Toxic and Adverse Effects of Chemotherapy with 5-Fluoropyrimidine Drugs. Could Dihydropyrimidine Dehydrogenase Enzyme Screening Serve as a Prerequisite to Successful Chemotherapy?

Journal of Biomedical and Clinical Research
Volume 13 (2020): Issue 2 (December 2020)
By: Velko T. Minchev  
Open Access
|Jan 2021

Authors

Velko T. Minchev

v_minchev@abv.bg

Department of Medical Oncology, SofiaMed University Multiprofile Hospital for Active Treatment
DOI: https://doi.org/10.2478/jbcr-2020-0013 | Journal eISSN: 1313-9053
Journal RSS Feed
Language: English
Page range: 87 - 99
Submitted on: Aug 17, 2020
|
Accepted on: Dec 11, 2020
|
Published on: Jan 21, 2021
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
5-Fluoropyrimidines chemotherapies,
Dihydropyrimidine dehydrogenase screening,
cost-effect analysis
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Ophthalmology,
Public health,
Pharmacy,
Clinical pharmacy

© 2021 Velko T. Minchev, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 13 (2020): Issue 2 (December 2020)Next article